GLAXF - GlaxoSmithKline (GSK) CEO Emma Walmsley on Q4 2020 Results - Earnings Call Transcript

GlaxoSmithKline (GSK) Q4 2020 Earnings Conference Call February 3, 2021 9:00 am ET Company Participants Emma Walmsley - Chief Executive Officer Iain Mackay - Chief Financial Officer Luke Miels - President, Global Pharmaceuticals David Redfern - Chief Strategy Officer Brian McNamara - Chief Executive Officer, GSK Consumer Healthcare Hal Barron - Chief Scientific Officer Roger Connor - President, Global Vaccines Conference Call Participants James Gordon - JP Morgan James Quigley - Morgan Stanley Laura Sutcliffe - UBS Geoffrey Porges - Leerink Graham Perry - Bank of America Jo Walton - Credit Suisse Louise Pearson - Redburn Andrew Baum - Citi Presentation Operator Good afternoon ladies and gentlemen and welcome to the analyst call on the GSK fourth quarter 2020 results. I will now hand you over to Iain Mackay, Chief Financial Officer who will introduce today’s session. Iain Mackay Good morning and good afternoon. Thank you for joining us for

For further details see:

GlaxoSmithKline (GSK) CEO, Emma Walmsley on Q4 2020 Results - Earnings Call Transcript